Comments

iBio Inc Stock Price, Quotes and Forecasts

Q: What sector and industry does iBio Inc (IBIO) operate in?

iBio Inc is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

IBIONASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$6.49

0.081.25%

After Hours: 9:29 AM EDT

iBio Inc (IBIO) Forecast

News Earnings iBio Inc (IBIO) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

iBio Inc Stock Price, Quotes and Forecasts | NASDAQ:IBIO | Benzinga

Explore iBio Inc stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for IBIO.

Open	$6.47
Close	-
Volume / Avg.	749.61K / 383.07K
Day Range	$5.42 - $6.47
52 Wk Range	1.05 - 6.89
Market Cap	$64.09M
P/E Ratio	4.93
Dividend Yield	-
Exchange	NASDAQ
RSI	74
Short Interest	-
Days to Cover	1.44

Recent News

Nano-Cap iBio Expands Obesity Program With New Antibody Using In-Licensed Platform

iBio advances obesity treatment with IBIO-600, a long-acting anti-myostatin antibody designed for subcutaneous use, targeting reduced dosing frequency.

Vandana Singh

AAR, ShiftPixy And 3 Stocks To Watch Heading Into Monday

Avi Kapoor

Micro-Cap Stock iBio Doubles On Wednesday - Here's Why

iBio surged after collaborating with AstralBio Inc. to develop antibodies for obesity & cardiometabolic conditions. Shares soared over 100%, hitting $2.44. Collaboration aims to target TGFb superfamily for muscle wasting & obesity treatment.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Dec 24

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$6.47
Close	-
Volume / Avg.	749.61K / 383.07K
Day Range	$5.42 - $6.47
52 Wk Range	1.05 - 6.89
Market Cap	$64.09M
P/E Ratio	4.93
Dividend Yield	-
Exchange	NASDAQ
RSI	74
Short Interest	-
Days to Cover	1.44

About iBio Inc

Sector

Health Care

Industry

Biotechnology

iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelli...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy iBio Inc (IBIO) stock?

You can purchase shares of iBio Inc (NASDAQ:IBIO) through any online brokerage.

View our list of the best stock brokerages

Who are iBio Inc (IBIO) competitors?

Other companies in iBio Inc’s space includes: Inozyme Pharma (NASDAQ:INZY), Burning Rock Biotech (NASDAQ:BNR), Inovio Pharmaceuticals (NASDAQ:INO), Adicet Bio (NASDAQ:ACET) and Agenus (NASDAQ:AGEN).

What is the forecast, or price target, for iBio Inc (IBIO) stock?

iBio Inc has a consensus price target of $3.69.

What is the current price for iBio Inc (IBIO)?

The stock price for iBio Inc (NASDAQ: IBIO) is $6.49 last updated March 4, 2025 at 9:29 AM EST.

Does iBio Inc (IBIO) pay a dividend?

There are no upcoming dividends for iBio Inc.

When is iBio Inc (NASDAQ:IBIO) reporting earnings?

iBio Inc’s Q3 earnings are confirmed for Monday, May 12, 2025.

Is iBio Inc (IBIO) going to split?

There is no upcoming split for iBio Inc.

What sector and industry does iBio Inc (IBIO) operate in?

iBio Inc is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.